Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global polymeric biomaterials market is expected to grow in the forecast period of 2022-2027 at a CAGR of 15.70%.
The increasing use of synthetic polymeric biomaterials for pericardial repair is driving the cardiology segment growth based on application. In addition to this, three-dimensional polymeric systems made from synthetic and natural biomaterials are gaining traction in cardiac post-infarction therapy.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
This factor is likely to propel the demand for polymeric biomaterials in the forecast period. Furthermore, the rising cases of cardiovascular diseases among the geriatrics, coupled with the increasing inclination of cardiologists towards biomimetic devices based on synthetic or natural polymers are anticipated to aid the market.
The polymeric biomaterials industry in North America is driven by the rising investments in the development of efficient drug delivery systems and advanced healthcare infrastructure, the growing collaborations to further research activities, and a strong foothold of the leading biopharmaceutical companies in the United States. In addition to this, increased competition among the raw material providers and high investment opportunities in the region for biopharma companies are anticipated to augment the market growth in the region.
Polymeric biomaterials are defined as polymer-based biomaterials which interact with biological systems for medical purposes. Therefore, polymeric biomaterials are mainly utilised for therapeutic applications. In addition to this, biomaterials can be natural, synthetic, or hybrid.
Based on application, the market can be segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The rising healthcare expenditure due to increasing health consciousness and increasing prevalence of chronic diseases is driving the market. This is further supported by the increasing disposable incomes and the rising geriatric population. Additionally, the increasing investments in pharmaceutical and therapeutic industries in emerging economies to make medical facilities more accessible are anticipated to augment the market growth. Moreover, the growing demand for polymeric biomaterials in the treatment of cardiac post-infarction injuries is likely to provide impetus to the market in the forecast period.
The report gives a detailed analysis of the following key players in the global polymeric biomaterials market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, Region|
|Breakup by Application||Neurology, Cardiology, Orthopaedics, Wound Care, Others|
|Breakup by Region||North America, Europe, Asia Pacific, Latin America, Middle East and Africa|
|Market Dynamics||SWOT, Porter's Five Forces, Key Indicators for Price and Demand|
|Competitive Landscape||Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications|
|Companies Covered||Corbion NV, Bezwada Biomedicals, LLC, DSM Biomedical B.V., BASF SE, Covestro AG, Evonik Industries AG, Starch Medical, Inc., Others|
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 Global Polymeric Biomaterials Market Analysis
8.1 Key Industry Highlights
8.2 Global Polymeric Biomaterials Historical Market (2017-2021)
8.3 Global Polymeric Biomaterials Market Forecast (2022-2027)
8.4 Global Polymeric Biomaterials Market by Application
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2017-2021)
126.96.36.199 Forecast Trend (2022-2027)
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2017-2021)
220.127.116.11 Forecast Trend (2022-2027)
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2017-2021)
126.96.36.199 Forecast Trend (2022-2027)
8.4.4 Wound Care
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2017-2021)
220.127.116.11 Forecast Trend (2022-2027)
8.5 Global Polymeric Biomaterials Market by Region
8.5.1 Market Share
18.104.22.168 North America
22.214.171.124 Asia Pacific
126.96.36.199 Latin America
188.8.131.52 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
184.108.40.206 United States of America
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
220.127.116.11 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
18.104.22.168 Saudi Arabia
22.214.171.124 United Arab Emirates
126.96.36.199 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Corbion NV
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
12.2.2 Bezwada Biomedicals, LLC
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.3 DSM Biomedical B.V.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
12.2.4 BASF SE
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.5 Covestro AG
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
12.2.6 Evonik Industries AG
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.7 Starch Medical, Inc.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Polymeric Biomaterials Market: Key Industry Highlights, 2017 and 2027
2. Global Polymeric Biomaterials Historical Market: Breakup by Application (USD Million), 2017-2021
3. Global Polymeric Biomaterials Market Forecast: Breakup by Application (USD Million), 2022-2027
4. Global Polymeric Biomaterials Historical Market: Breakup by Region (USD Million), 2017-2021
5. Global Polymeric Biomaterials Market Forecast: Breakup by Region (USD Million), 2022-2027
6. North America Polymeric Biomaterials Historical Market: Breakup by Country (USD Million), 2017-2021
7. North America Polymeric Biomaterials Market Forecast: Breakup by Country (USD Million), 2022-2027
8. Europe Polymeric Biomaterials Historical Market: Breakup by Country (USD Million), 2017-2021
9. Europe Polymeric Biomaterials Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Asia Pacific Polymeric Biomaterials Historical Market: Breakup by Country (USD Million), 2017-2021
11. Asia Pacific Polymeric Biomaterials Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Latin America Polymeric Biomaterials Historical Market: Breakup by Country (USD Million), 2017-2021
13. Latin America Polymeric Biomaterials Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Middle East and Africa Polymeric Biomaterials Historical Market: Breakup by Country (USD Million), 2017-2021
15. Middle East and Africa Polymeric Biomaterials Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Global Polymeric Biomaterials Market Structure
The market is estimated to grow at a CAGR of 15.70% between 2022 and 2027.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the industry, such as the rising healthcare expenditure, rising cases of chronic diseases, and the growing competition among pharmaceutical companies, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing research and development activities in the biopharmaceutical sector.
Neurology, cardiology, orthopaedics, and wound care, among others are the different applications.
The major players in the industry are Corbion NV, Bezwada Biomedicals, LLC, DSM Biomedical B.V., BASF SE, Covestro AG, Evonik Industries AG, and Starch Medical, Inc., among others.
The global polymeric biomaterials market is driven by the rising cases of chronic cases, increasing healthcare expenditure, and rapid technological advancements in the medical sector. Aided by the growing innovations by key industry players, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 15.70%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of application, the market is divided into neurology, cardiology, orthopaedics, and wound care, among others. The major regional markets for polymeric biomaterials are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Corbion NV, Bezwada Biomedicals, LLC, DSM Biomedical B.V., BASF SE, Covestro AG, Evonik Industries AG, and Starch Medical, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.